DNAPrint Genomics, Inc.
DNAG
$0.00
$0.000.00%
OTC PK
| 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Revenue | -15.16% | 21.31% | 43.33% | 90.75% | 118.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.16% | 21.31% | 43.33% | 90.75% | 118.21% |
| Cost of Revenue | -8.88% | 16.89% | 24.49% | 76.63% | 129.78% |
| Gross Profit | -31.01% | 34.01% | 109.48% | 131.96% | 93.68% |
| SG&A Expenses | -35.77% | -19.17% | -3.61% | 11.51% | 49.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.55% | 4.66% | 24.98% | 90.33% | 127.32% |
| Operating Income | 27.02% | -0.26% | -20.09% | -90.21% | -129.85% |
| Income Before Tax | 63.65% | 43.31% | 36.77% | -41.68% | -122.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.65% | 43.31% | 36.77% | -41.68% | -122.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.65% | 43.31% | 36.77% | -41.68% | -122.35% |
| EBIT | 27.02% | -0.26% | -20.09% | -90.21% | -129.85% |
| EBITDA | 29.32% | 1.48% | -18.29% | -87.65% | -128.87% |
| EPS Basic | 80.39% | 73.84% | 79.82% | 65.83% | 53.46% |
| Normalized Basic EPS | 67.71% | 63.77% | 73.71% | 69.57% | 52.86% |
| EPS Diluted | 77.96% | 72.18% | 74.15% | 62.30% | 49.95% |
| Normalized Diluted EPS | 70.49% | 66.09% | 75.13% | 69.57% | 52.86% |
| Average Basic Shares Outstanding | 73.97% | 107.84% | 176.36% | 291.50% | 433.47% |
| Average Diluted Shares Outstanding | 93.40% | 133.98% | 215.43% | 291.50% | 433.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |